Aikaterini Geladaki

Aikaterini Geladaki

GlaxoSmithKline
Verified email at gsk.com
Cited by 3373
stem cell biology pluripotency complex in vitro models functional genomics CRISPR screening platform development
Alexandre Ribeiro

Alexandre Ribeiro

Principal Analytical Scientist, Hovione, R&D
Verified email at hovione.com
Cited by 3181
Drug ADME Drug Pharmacology Drug Toxicity Complex In Vitro Models Stem Cells
Terry Van Vleet

Terry Van Vleet

Senior Director, Investigative Tox and Path, AbbVie
Verified email at AbbVie.com
Cited by 2585
computational toxicology renal toxicity mitochondrial toxicity carcinogenesis complex in vitro models
Terrence Roh

Terrence Roh

Principal Scientist, GSK
Verified email at gsk.com
Cited by 1131
Complex In Vitro Models Imaging Data Analysis
Guanyi Huang

Guanyi Huang

Merck & Co.
Cited by 965
Stem cells cardiovascular diseases complex in vitro models
Graham Marsh

Graham Marsh

Critical Path Institute
Verified email at c-path.org
Cited by 910
complex in vitro models
Julianna Deakyne

Julianna Deakyne

Investigator, GlaxoSmithKline
Verified email at gsk.com
Cited by 455
High Content Imaging Cellular Biology Complex In Vitro Models
Nikita Karra-Bhardwaj

Nikita Karra-Bhardwaj

GlaxoSmithKline
Verified email at gsk.com
Cited by 48
Complex In Vitro Models Organs-on-a-Chip Respiratory Diseases Neurodegenerative Diseases Drug
Yiyuan Zhang

Yiyuan Zhang

Post Doc Research Fellow, Merck
Verified email at merck.com
Cited by 41
complex in vitro models biomicrofluidics organ-on-a-chip 3D cell culture